Graham Collins/X
Jun 20, 2025, 16:16
Graham Collins: ctDNA in S1826 – Clearance at C3D1 Associated With PFS
Graham Collins, Associate Professor, Haematology and Lymphoma Specialist at Oxford Cancer and Haematology Centre, shared a post on X:
“Herrera et al – ctDNA in S1826
• 97% ctDNA + baseline
• clearance at C3D1 associated with PFS
• within pos patients, those with minor associated with esp poor outcomes
• EOT ctDNA detection also associated with poor outcomes CtDNA ripe for response adapted trials.”
More posts featuring Graham Collins on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 24, 2025, 01:32
Aug 23, 2025, 22:57
Aug 23, 2025, 22:35
Aug 23, 2025, 22:10
Aug 23, 2025, 21:42
Aug 23, 2025, 21:31
Aug 23, 2025, 20:55
Aug 23, 2025, 20:22